Biomarker Discovery and Validation: Statistical Considerations

被引:81
|
作者
Ou, Fang-Shu [1 ]
Michiels, Stefan [2 ]
Shyr, Yu [3 ]
Adjei, Alex A. [4 ]
Oberg, Ann L. [1 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, 200 First St SW, Rochester, MN 55905 USA
[2] Univ Paris Saclay, Dept Biostat & Epidemiol, Labelel Ligue Canc, INSERM,Gustave Roussy,Oncostat U1018,CESP, Villejuif, France
[3] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA
[4] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Biomarker; Exploratory analysis; Confirmation analysis; Clinical trial; CANCER; SPECIMENS; IMPACT; BIAS;
D O I
10.1016/j.jtho.2021.01.1616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes. Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes. ? 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:537 / 545
页数:9
相关论文
共 50 条
  • [41] Predictive biomarker discovery and validation for the targeted chemotherapeutic ixabepilone.
    Lee, H.
    Xu, L.
    Wu, S.
    Paul, B.
    Baselga, J.
    Llombart, A.
    Steger, G. G.
    Galbraith, S.
    Clark, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 123S - 123S
  • [42] CE-MS in biomarker discovery, validation, and clinical application
    Mischak, Harald
    Schanstra, Joost P.
    PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (1-2) : 9 - 23
  • [43] Artificial intelligence in salivary biomarker discovery and validation for oral diseases
    Adeoye, John
    Su, Yu-Xiong
    ORAL DISEASES, 2024, 30 (01) : 23 - 37
  • [44] Making the cut: untangling clinical protein biomarker discovery and validation
    Gold, Larry
    Williams, Stephen
    Janjic, Nebojsa
    Saccomano, Nick
    Steele, Fintan
    BIOMARKERS IN MEDICINE, 2011, 5 (02) : 189 - 191
  • [45] From biomarker discovery to proteomic validation using mass spectrometry
    Jylha, A.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 59 - 59
  • [46] DISCOVERY AND VALIDATION OF NEW AUTOANTIBODY BIOMARKER IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Budde, P.
    Vordenbaeumen, S.
    Chamrad, D.
    Schlieker, L.
    Telaar, A.
    Zucht, H. -D.
    Schulz-Knappe, P.
    Schneider, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 888 - 888
  • [47] Proteomic methods for biomarker discovery and validation. Are we there yet?
    Hathout, Yetrib
    EXPERT REVIEW OF PROTEOMICS, 2015, 12 (04) : 329 - 331
  • [48] Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics
    Tarasow, Theodore M.
    Penny, Laura
    Patwardhan, Anil
    Hamren, Sarah
    McKenna, Michael P.
    Urdea, Mickey S.
    BIOANALYSIS, 2011, 3 (19) : 2233 - 2251
  • [49] Biomarker Discovery: Validation and Decision-Making in Product Development
    Niedbala, R. Sam
    Mauck, Christine
    Harrison, Polly
    Doncel, Gustavo F.
    SEXUALLY TRANSMITTED DISEASES, 2009, 36 (03) : S76 - S80
  • [50] Global Transcriptional Analysis for Biomarker Discovery and Validation in Cellular Therapies
    Stroncek, David F.
    Jin, Ping
    Wang, Ena
    Ren, Jiagiang
    Sabatino, Marianna
    Marincola, Francesco M.
    MOLECULAR DIAGNOSIS & THERAPY, 2009, 13 (03) : 181 - 193